The short answer
A chronic total occlusion (CTO) is a coronary artery that has been completely blocked for at least three months. With modern techniques, experienced operators can reopen around 85–90% of CTOs through a keyhole procedure (PCI), without open-heart surgery. The best-proven benefit is relief of angina and breathlessness, so treatment is usually considered when symptoms persist despite medication.
What Is a Chronic Total Occlusion?
A coronary artery is classified as a chronic total occlusion (CTO) when it has been fully blocked — 100 per cent, with no blood flowing through that segment — for at least three months. The blockage is usually old, organised, and often hardened with calcium, which is part of what makes it so difficult to cross with a wire.
CTOs are found in roughly 16 to 25 per cent of patients who undergo coronary angiography and have significant coronary artery disease. Many turn up incidentally, and a fair number have been quietly present for years — silently shaping a person's capacity without them knowing the cause.
Despite being common, CTOs have long been the least treated blockages in cardiology. In one large Canadian registry, PCI of the blocked artery was attempted in only about 1 in 10 patients with a CTO, and 44 per cent were managed with medication alone.
The Heart's Workaround
When an artery closes slowly, the body often grows tiny natural bypass channels — called collaterals — from neighbouring arteries to keep the downstream muscle alive. These collaterals are why many people survive a total blockage without a large heart attack.
They are rarely enough, however, to supply the muscle properly during exertion — and this is where symptoms begin.
What a CTO Feels Like
The under-supplied heart muscle often makes its presence known during activity — when it is asked to do more than the collaterals can manage.
Effort-Related Chest Tightness
The most common symptom is angina — a tightness, pressure, or heaviness in the chest that comes on during exertion and settles with rest. It is the muscle signalling that its blood supply is not keeping up.
Breathlessness on Exertion
Some people notice breathlessness rather than chest pain — a sense of running out of air on a hill or stairs that previously caused no difficulty.
A Shrinking Radius of Activity
A slow decline in what is possible: a walk that used to be easy now needs a rest, or tasks that were routine have quietly become effortful. This gradual narrowing of life is one of the hallmarks of undertreated coronary disease.
No Symptoms at All
Not everyone with a CTO has symptoms. Where strong collaterals meet a modest workload, a person can feel well — and the blockage may reasonably be left alone. Symptoms, rather than the mere presence of a blockage on a scan, are what should drive any decision to intervene.
How Treatment Has Changed
For most of the history of angioplasty, a CTO was where the interventional cardiologist stopped. Success rates in large all-comers registries sat around 53 to 59 per cent, procedures were long, and risk did not justify the reward. That picture has been rewritten over the past 15 years.
A dedicated global community of operators built a structured toolkit — working both forwards from the near side of the occlusion and backwards through the collateral channels from the far side. Purpose-made wires, microcatheters, and imaging now exist for exactly this task. The European Registry of Chronic Total Occlusion (ERCTO), reporting on over 8,600 procedures between 2021 and 2022, recorded an overall technical success rate of 89.1 per cent.
What Opening a CTO Can — and Cannot — Do
What the Evidence Supports
The clearest and best-proven benefit of successfully opening a CTO is relief of symptoms. A pooled analysis of the two largest randomised trials — EuroCTO and DECISION-CTO — found that PCI was superior to optimal medical therapy for improvement in:
- Angina frequency at 12 months
- Quality of life scores
- Overall symptom burden
People often get their capacity back, reduce anti-anginal medication, and return to activities they had given up.
In 2026, the first placebo-controlled trial (ORBITA-CTO) found that, compared with a sham procedure, opening a CTO reduced angina and improved quality of life in carefully selected patients with a single blocked artery. The trial was small, and some people in the placebo group also felt better.
What the Evidence Does Not Show
What the randomised evidence does not show is that routinely opening a CTO makes a person live longer or prevents future heart attacks.
In the DECISION-CTO trial, there was no significant difference in the composite of death, myocardial infarction, stroke, or revascularisation between CTO PCI and medical therapy over a median follow-up of four years.
This means a CTO procedure is done chiefly to help a person feel and function better — not as an emergency, and not, in most cases, as a life-saving necessity.
The Risks, Honestly
Opening a chronic total occlusion asks more — and carries more risk — than a routine angioplasty. The blockage is hardened and complete, the approach sometimes runs backwards through delicate collateral channels, and the work can take time. These risks are real, but they are manageable in the right setting.
Coronary Perforation
Reported in approximately 4–5% of CTO PCIs at experienced centres. Most are managed during the procedure; roughly 14% of those who experience a perforation require drainage of fluid from around the heart.
Periprocedural Infarction
A small myocardial infarction can occur during the procedure. The risk is higher than in standard PCI, reflecting the complexity of the work involved.
Collateral Vessel Damage
When a retrograde approach is used, the vessel supplying the collaterals can be damaged. This is one reason that retrograde skill is inseparable from safe retrograde practice.
In-Hospital Major Events
Major adverse cardiac events range from 1–3% at experienced centres, according to the 2021 ACC/AHA/SCAI Guideline — though rates are higher in all-comers registries and among less experienced operators.
Serious complications are uncommon in high-volume centres but are never zero — and they become meaningfully more likely when the operator performs this procedure occasionally rather than routinely.
Why It Matters So Much Who Does It
CTO work is a subspecialty within a subspecialty. Not every interventional cardiologist performs it, and among those who do, there is a wide gulf between the operator who attempts a handful a year.
ERCTO Success Rate
Overall technical success reported across 8,600+ procedures, 2021–2022
Success rate: more than 60 vs fewer than 30 CTO procedures a year (PROGRESS-CTO)
In a large multicentre registry (PROGRESS-CTO), operators performing more than 60 CTO procedures a year had higher success rates (about 88%) than those performing fewer than 30 (about 83%), even though they treated more complex cases.
Experience Gap
Success rates ranged from 45% in the lowest experience tertile to 65% in the highest (Blue Cross Blue Shield of Michigan registry)
The reason is that opening these arteries is not one technique but a whole toolkit. It means being fluent in the forward approach and the backward one, knowing when to switch between them, navigating collateral channels the width of a hair, and having done it often enough to stay calm and exact when a case turns difficult. That fluency comes from dedicated training — and from volume. It cannot be improvised on the day.
Questions Worth Asking Your Operator
It is entirely reasonable — and genuinely sensible — to ask direct questions before proceeding with a CTO procedure. A dedicated, experienced operator will welcome them and answer plainly. Here is what to ask:
"How many CTO procedures do you perform each year?"
Volume is one of the strongest predictors of success. An operator performing dozens annually will have a substantially different skill set from one doing a handful.
"Are you specifically trained in the retrograde approach?"
The retrograde technique — approaching the blockage backwards through collateral channels — is the more demanding half of the CTO toolkit. Not all operators are trained in it, and its absence limits what can be attempted safely.
"What are your personal success and complication rates?"
Published registries provide benchmarks. An experienced operator should be able to speak to their own outcomes and how they compare with the published literature.
"Has my case been discussed with a heart team?"
A good CTO decision involves the interventional cardiologist alongside colleagues — weighing symptoms, the state of all arteries, the amount of living muscle at stake, and whether bypass surgery or medication might serve the patient better.
What the Procedure Involves
A CTO procedure takes place in a cardiac catheterisation laboratory, usually through a small puncture in the wrist, the groin, or occasionally both. Fine wires and catheters are guided to the heart, the blockage is crossed, and the artery is opened with balloons and stents — restoring blood flow through it for the first time in months or years.
Depending on the complexity of the lesion and the approach required, the procedure can take from under an hour to several hours. Most people stay in hospital overnight and go home the following day, with a short recovery period.
The Decision-Making Process
Bypass surgery is sometimes the better answer — particularly when several arteries are involved. Medication alone is sometimes right, especially when symptoms are mild or collaterals are functioning well. A good CTO decision is never made in isolation; it is always arrived at through a considered heart team discussion that places the patient's symptoms, anatomy, and preferences at the centre.
Referral Guidance & Access
When to Refer
A CTO warrants referral when a patient has angina or exertional breathlessness attributable to a known or suspected totally occluded vessel — particularly when symptoms persist despite optimal medical therapy, or when a substantial territory of viable myocardium is subtended by the occlusion.
Incidental, asymptomatic CTOs with good collateral support and no significant ischaemic burden generally do not require intervention. Referral is best framed as an elective quality-of-life intervention for symptom relief and functional gain in appropriately selected cases, rather than a prognostic one.
What to Include in the Referral
- Prior invasive angiography or CT coronary angiography
- Assessment of symptom burden and functional limitation
- Current anti-anginal therapy
- Renal function and relevant comorbidities
Evidence Summary for Counselling
The pooled analysis of EuroCTO and DECISION-CTO supports improvement in angina frequency and quality of life following successful CTO PCI, without a demonstrated reduction in mortality or myocardial infarction. The 2021 ACC/AHA/SCAI Guideline assigns a Class 2b (Level of Evidence B-R) recommendation for patients with suitable anatomy and refractory angina on medical therapy.
Local Access
The pathway runs through the GP or treating cardiologist, either of whom can arrange specialist review. The procedure is performed in cardiac catheterisation laboratories with multidisciplinary support; Medicare and private health cover apply as they do for other coronary intervention. Waiting times and out-of-pocket costs differ between systems and are worth raising openly at the consultation.
For GPs
- When to refer: angina or exertional breathlessness despite at least two anti-anginal agents with a known or suspected CTO on CTCA or angiography, or a large ischaemic territory or unexplained LV dysfunction in the CTO territory. Asymptomatic CTOs with good collaterals usually do not need intervention.
- Optimise first: anti-anginals, high-intensity statin to LDL target and antiplatelet therapy before or alongside referral. CTO PCI is for symptom relief, not prognosis. (ESC 2024 CCS)
- What to send: angiogram or CTCA report (images or disc if available), any ischaemia or viability test, echo/LVEF, eGFR, HbA1c, contrast allergy history and current medicines including anticoagulants.
- Kidneys: CTO PCI can use large contrast volumes; flag eGFR below 45 and diabetes on metformin.
- After the procedure: usual default is DAPT for 6 months after elective stenting; do not stop antiplatelets early without discussing with the treating cardiologist. New chest pain, breathlessness or falling BP in the days after warrants same-day review (delayed effusion or haematoma).
General information for referring practitioners. Check current MBS and PBS criteria before acting.
Frequently asked questions
Can a 100% blocked artery be opened?
Often, yes. In the European CTO registry of over 8,600 procedures, technical success was 89%. Results depend strongly on the operator's experience with these procedures.
Will opening a CTO help me live longer?
The clearest evidence is for better symptoms and quality of life. A survival benefit hasn't been proven in randomised trials, so the decision is usually driven by symptoms.
What are the risks?
CTO PCI carries more risk than routine stenting. For example, a perforation of the artery is reported in about 4–5% of procedures at experienced centres. Complications are uncommon in high-volume centres but never zero.
I've been told nothing more can be done. Can I get a second opinion?
Yes. Dr Ng sees patients who have been declined bypass surgery or who are seeking a second opinion. Ask your GP for a referral.